JIC
TAK icon

Johnson Investment Counsel’s Takeda Pharmaceutical TAK Stock Holding History

Johnson Investment Counsel’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-10,476
Closed -$162K – 734
2023
Q3 		$162K Sell
10,476
-485
-4% -$7.51K ﹤0.01% 645
2023
Q2 		$172K Sell
10,961
-67
-0.6% -$1.1K ﹤0.01% 644
2023
Q1 		$182K Sell
11,028
-251
-2% -$4K ﹤0.01% 634
2022
Q4 		$176K Sell
11,279
-101
-0.9% -$1.41K ﹤0.01% 634
2022
Q3 		$148K Buy
11,380
+101
+0.9% +$1.4K ﹤0.01% 619
2022
Q2 		$158K Buy
11,279
+1,006
+10% +$14.4K ﹤0.01% 627
2022
Q1 		$147K Sell
10,273
-400
-4% -$5.87K ﹤0.01% 648
2021
Q4 		$145K Sell
10,673
-3,927
-27% -$55.1K ﹤0.01% 650
2021
Q3 		$239K Sell
14,600
-819
-5% -$13.7K ﹤0.01% 588
2021
Q2 		$266K Sell
15,419
-378
-2% -$6.43K ﹤0.01% 558
2021
Q1 		$288K Sell
15,797
-517
-3% -$9.3K ﹤0.01% 513
2020
Q4 		$297K Sell
16,314
-75
-0.5% -$1.32K ﹤0.01% 498
2020
Q3 		$292K Sell
16,389
-196
-1% -$3.57K 0.01% 479
2020
Q2 		$304K Buy
16,585
+80
+0.5% +$1.44K 0.01% 480
2020
Q1 		$251K Hold
16,505
– – 0.01% 479
2019
Q4 		$326K Buy
16,505
+200
+1% +$3.83K 0.01% 492
2019
Q3 		$280K Buy
+16,305
New +$282K 0.01% 514

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.69B AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Johnson Investment Counsel's TAK Position: Q4 2023 in Review

Johnson Investment Counsel sold out of Takeda Pharmaceutical (TAK) in Q4 2023, closing a stake of 10,476 shares — an estimated $162K sold.

Johnson Investment Counsel first reported a position in TAK in Q3 2019 and held it in 17 quarters. The position peaked at $326K in Q4 2019. 306 funds tracked by Wall St. Rank hold TAK as of Q4 2023.

  • Johnson Investment Counsel reported no remaining Takeda Pharmaceutical position as of Q4 2023 after selling out during the quarter.
  • Johnson Investment Counsel sold 10,476 Takeda Pharmaceutical shares in Q4 2023, an estimated $162K.
  • Johnson Investment Counsel first reported a position in Takeda Pharmaceutical in Q3 2019 and held it in 17 quarters.
  • Johnson Investment Counsel's Takeda Pharmaceutical position peaked at $326K in Q4 2019.
  • 306 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q4 2023.

Based on Johnson Investment Counsel's 13F filing for Q4 2023, filed 7 Feb 2024.